Cargando…

Circulating and Disseminated Tumor Cells in the Management of Advanced Prostate Cancer

Management of prostate cancer is recognized as one of the most important medical problems. Latest findings concerning the role of circulating (CTC) and disseminated tumor cells (DTC) have provided new insights into the biology of metastasis with important implications for the clinical management of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kruck, Stephan, Gakis, Georgios, Stenzl, Arnulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159300/ https://www.ncbi.nlm.nih.gov/pubmed/21869883 http://dx.doi.org/10.1155/2012/135281

Ejemplares similares

Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma
por: Bedke, Jens, et al.
Publicado: (2015)

Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019)

A Rare Case of Synchronous Renal Cell Carcinoma of the Bladder Presenting With Gross Hematuria
por: Kruck, Stephan, et al.
Publicado: (2013)

Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
por: Todenhöfer, Tilman, et al.
Publicado: (2015)

Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy
por: Thaiss, Wolfgang M., et al.
Publicado: (2022)

Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma
por: Kruck, Stephan, et al.
Publicado: (2013)

Micro-Ultrasound: a way to bring imaging for prostate cancer back to urology
por: Harland, Niklas, et al.
Publicado: (2021)

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study
por: Horstmann, Marcus, et al.
Publicado: (2014)

The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination
por: Szczerba, Anna, et al.
Publicado: (2022)

T2 mapping for the characterization of prostate lesions
por: Hepp, Tobias, et al.
Publicado: (2022)

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria
por: Hennenlotter, Joerg, et al.
Publicado: (2011)

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer
por: Hegemann, Miriam, et al.
Publicado: (2019)

Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate Cancer
por: Harland, Niklas, et al.
Publicado: (2021)

Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
por: Cieślikowski, Wojciech A., et al.
Publicado: (2021)

Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review
por: Walz, Simon, et al.
Publicado: (2020)

Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014)

Long-term results after endoscopic VUR-treatment using dextranomer / hyaluronic acid copolymer – 5-year experience in a single-center
por: Seibold, Joerg, et al.
Publicado: (2011)

Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer
por: Oakman, Catherine, et al.
Publicado: (2010)

Circulating Tumor Cells in Prostate Cancer
por: Hu, Brian, et al.
Publicado: (2013)

Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
por: Erne, Eva, et al.
Publicado: (2021)

Role of laparoscopy in ureteropelvic junction obstruction with concomitant pathology: a case series study
por: Fahmy, Omar, et al.
Publicado: (2015)

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021)

Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
por: Dasgupta, Arko, et al.
Publicado: (2017)

The importance of circulating and disseminated tumor cells in pancreatic cancer
por: Hasanain, Alina, et al.
Publicado: (2019)

Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination
por: Noubissi Nzeteu, Gaetan Aime, et al.
Publicado: (2022)

Is a single portal venous phase in contrast-enhanced CT sufficient to detect metastases or recurrence in clear cell renal cell carcinoma? – a single-center retrospective study
por: Hagen, Florian, et al.
Publicado: (2022)

Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy
por: Hogh-Binder, Sophia A., et al.
Publicado: (2023)

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2020)

Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion
por: Wang, Hongxia, et al.
Publicado: (2016)

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2015)

Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
por: Cimadamore, Alessia, et al.
Publicado: (2020)

Circulating tumor cells capture disease evolution in advanced prostate cancer
por: Lack, Justin, et al.
Publicado: (2017)

Intracorporeal ileal ureter replacement using laparoscopy and robotics
por: Sim, Allen, et al.
Publicado: (2014)

AUTHOR'S REPLY
por: Sim, Allen, et al.
Publicado: (2014)

Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder Cancer
por: Gakis, Georgios, et al.
Publicado: (2016)

Circulating tumor cells in prostate cancer: Precision diagnosis and therapy
por: Liu, Weiwei, et al.
Publicado: (2017)

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
por: Lorente, David, et al.
Publicado: (2016)

Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis
por: Cui, Long, et al.
Publicado: (2015)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g1hnvpmeg55b3o40v42b614reo